MicroVision director receives 22,007 shares via RSU vest

MICROVISION, INC. director Jada Smith reported the vesting of restricted stock units that converted into common shares.

Rhea-AI Filing Summary

MICROVISION, INC. director Jada Smith reported the vesting of restricted stock units that converted into common shares. On March 2, 2026, 22,007 RSUs were exercised at $0.00 per unit into 22,007 shares of common stock, bringing her direct common stock holdings to 126,358 shares.

Insider Trade Summary

22,007 shares exercised/converted

Exercise 2 txns

Insider Smith Jada

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	22,007	$0.00	$0.00
Exercise	Common Stock	22,007	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 126,358 shares (Direct)

Footnotes (3)

1. F1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
2. F2. At vesting, RSUs convert into shares of common stock on a unit-for-share basis, without payment.
3. F3. RSUs granted 06/06/2025 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date. The Form 4 filed on 06/06/2025 incorrectly reported the total RSUs granted on 06/05/2025 as 87,462 RSUs instead of the correct amount of 88,208 RSUs. The vesting reported herein was calculated based on the correct amount of 88,028 RSUs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MicroVision (MVIS) director Jada Smith report on this Form 4?

Jada Smith reported the vesting of restricted stock units that converted into common stock. On March 2, 2026, 22,007 RSUs were exercised at $0.00 per unit into 22,007 MicroVision common shares, increasing her directly held stake to 126,358 shares.

How many MicroVision (MVIS) shares did Jada Smith acquire in this transaction?

She acquired 22,007 shares of MicroVision common stock through RSU vesting. The restricted stock units converted on a one-for-one basis into common shares at no cash cost, reflecting an exercise or conversion of a derivative security rather than an open-market purchase.

What is Jada Smith’s MicroVision (MVIS) ownership after this Form 4 event?

After the RSU vesting and conversion, Jada Smith directly holds 126,358 shares of MicroVision common stock. This total reflects the addition of 22,007 newly delivered shares from vested restricted stock units credited to her on March 2, 2026.

Was cash paid for the MicroVision (MVIS) RSU conversion reported by Jada Smith?

No cash was paid for this transaction. The filing states that vested restricted stock units converted into MicroVision common stock on a unit-for-share basis at $0.00 per share, meaning the director received the shares without making a cash payment to exercise them.

What do the footnotes reveal about Jada Smith’s MicroVision (MVIS) RSUs?

The footnotes explain that vested RSUs automatically convert into common stock on a one-for-one basis without payment. They also clarify that a prior Form 4 misreported the total RSUs granted, and this vesting was calculated using the corrected RSU grant amount.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 09:56 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Jada

(Last) (First) (Middle)

18390 NE 68TH STREET

(Street)

REDMOND WA 98052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		M		22,007	A	$0.00(1)	126,358	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.00(2)	03/02/2026		M			22,007	03/02/2026(3)	03/02/2026(3)	Common stock	22,007	$0.00	0	D

Explanation of Responses:

1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.

2. At vesting, RSUs convert into shares of common stock on a unit-for-share basis, without payment.

3. RSUs granted 06/06/2025 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date. The Form 4 filed on 06/06/2025 incorrectly reported the total RSUs granted on 06/05/2025 as 87,462 RSUs instead of the correct amount of 88,208 RSUs. The vesting reported herein was calculated based on the correct amount of 88,028 RSUs.

	/s/ Drew G. Markham, attorney-in-fact for Jada Smith	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.